The randomized, placebo-controlled, double-blind phase 1 trial will feature 240 male and female subjects aged between 18 and 49. It will assess the safety and immunogenicity of the investigational
Eylea injection is a vascular endothelial growth factor (VEGF) inhibitor formulated as an injection for the eye. It is designed to inhibit the growth of new blood vessels
The new research hub will focus its research on early bioscience discovery and entrepreneurial innovation. According to MSD, by locating a research hub in London, it will be
Tagrisso is a third-generation and irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with clinical activity against central nervous system (CNS) metastases. It is designed to
Riomet was approved in the US for the treatment of type 2 diabetes mellitus in adult and children age 10 and above. The diabetes oral solution is manufactured
The trial, dubbed WISTERIA, will assess the effectiveness of the pharma company’s experimental compound AZD1775, in combination with chemotherapy prior to surgery or with chemotherapy and radiotherapy after surgery.
Through the study, it was discovered that people who used lansoprazole, a widely used gastric acid suppressant were a third less likely to get TB, as opposed to
Juluca is said to be the first 2DR, which includes dolutegravir 50mg produced by ViiV Healthcare and rilpivirine 25mg produced by Janssen Therapeutics. Dolutegravir 50mg is an integrase
The CMA has provisionally found that Concordia overcharged the NHS by millions for the thyroid drug by increasing the price of a pack of liothyronine tablets from about £4.46 prior to its
Tasigna has also been approved for the treatment of pediatric patients with Ph+ CML-CP with resistance or intolerance to prior therapy including imatinib. Tasigna said to be the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.